Literature DB >> 33442928

Implementation of tripartite estimands using adherence causal estimators under the causal inference framework.

Yongming Qu1, Junxiang Luo2, Stephen J Ruberg3.   

Abstract

Intercurrent events (ICEs) and missing values are inevitable in clinical trials of any size and duration, making it difficult to assess the treatment effect for all patients in randomized clinical trials. Defining the appropriate estimand that is relevant to the clinical research question is the first step in analyzing data. The tripartite estimands, which evaluate the treatment differences in the proportion of patients with ICEs due to adverse events, the proportion of patients with ICEs due to lack of efficacy, and the primary efficacy outcome for those who can adhere to study treatment under the causal inference framework, are of interest to many stakeholders in understanding the totality of treatment effects. In this manuscript, we discuss the details of how to estimate tripartite estimands based on a causal inference framework and how to interpret tripartite estimates through a phase 3 clinical study evaluating a basal insulin treatment for patients with type 1 diabetes.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  ICH E9 (R1); adherence; intercurrent events; missing data; principal stratification

Year:  2020        PMID: 33442928     DOI: 10.1002/pst.2054

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  2 in total

1.  Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic.

Authors:  Yongming Qu; Ilya Lipkovich
Journal:  Ther Innov Regul Sci       Date:  2021-05-13       Impact factor: 1.337

2.  Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey.

Authors:  C Fletcher; N Hefting; M Wright; J Bell; J Anzures-Cabrera; D Wright; H Lynggaard; A Schueler
Journal:  Ther Innov Regul Sci       Date:  2022-04-24       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.